PUBLISHER: Transparency Market Research | PRODUCT CODE: 1140626

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1140626

Critical Limb Ischemia Treatment Market (Treatment: Medications, and Devices: Embolic Protection Devices and Peripheral Dilatation System) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

PUBLISHED: August 12, 2022

PAGES: 211 Pages

DELIVERY TIME: 2-10 business days

SELECT AN OPTION

The report provides revenue of the global critical limb ischemia treatment market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global critical limb ischemia treatment market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the critical limb ischemia treatment market.

The report delves into the competitive landscape of the global critical limb ischemia treatment market. Key players operating in the global critical limb ischemia treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global critical limb ischemia treatment market profiled in this report.

Product Code: TMRGL2770

1. Preface

1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology

2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary

4. Market Overview

4.1. Product Overview
4.2. Market Dynamics
- 4.2.1. Drivers and Restraints Snapshot Analysis
- 4.2.2. Drivers
- 4.2.3. Restraints
- 4.2.4. Opportunity
4.3. Global Critical Limb Ischemia Treatment Market Revenue Projection (US$ Mn), 2017-2027
4.4. Global Critical Limb Ischemia Treatment Market Outlook

5. Market Outlook

5.1. Pipeline Analysis
5.2. Key Industry Events
5.3. Regulatory Scenario for Device
5.4. Prevalence of Critical Limb Ischemia Globally/Region
5.5. Major Research Institutes Involved
5.6. Technological Advancement

6. Global Critical Limb Ischemia Treatment Market Analysis, by Treatment

6.1. Key Findings
6.2. Introduction
6.3. Global Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
6.4. Global Critical Limb Ischemia Treatment Market Forecast, by Treatment
- 6.4.1. Devices
- 6.4.2. Medication
6.5. Global Critical Limb Ischemia Treatment Market Analysis, by Treatment

7. Global Critical Limb Ischemia Treatment Market Analysis, by Region

7.1. Global Critical Limb Ischemia Treatment Market Scenario, by Country
7.2. Global Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Region
7.3. Global Critical Limb Ischemia Treatment Market Forecast, by Region
- 7.3.1. North America
- 7.3.2. Europe
- 7.3.3. Asia Pacific
- 7.3.4. Latin America
- 7.3.5. Middle East & Africa

8. North America Critical Limb Ischemia Treatment Market Analysis

8.1. Key Findings
8.2. North America Critical Limb Ischemia Treatment Market Overview
8.3. North America Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country
8.4. North America Critical Limb Ischemia Treatment Market Forecast, by Country
- 8.4.1. U.S.
- 8.4.2. Canada
8.5. North America Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
8.6. North America Critical Limb Ischemia Treatment Market Forecast, by Treatment
- 8.6.1. Devices
- 8.6.2. Medication

9. Europe Critical Limb Ischemia Treatment Market Analysis

9.1. Key Findings
9.2. Europe Critical Limb Ischemia Treatment Market Overview
9.3. Europe Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
9.4. Europe Critical Limb Ischemia Treatment Market Forecast, by Country/Sub-region
- 9.4.1. Germany
- 9.4.2. France
- 9.4.3. U.K.
- 9.4.4. Italy
- 9.4.5. Spain
- 9.4.6. Rest of Europe
9.5. Europe Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
9.6. Europe Critical Limb Ischemia Treatment Market Forecast, by Treatment
- 9.6.1. Devices
- 9.6.2. Medication

10. Asia Pacific Critical Limb Ischemia Treatment Market Analysis

10.1. Key Findings
10.2. Asia Pacific Critical Limb Ischemia Treatment Market Overview
10.3. Asia Pacific Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
10.4. Asia Pacific Critical Limb Ischemia Treatment Market Forecast, by Country/Sub-region
- 10.4.1. Japan
- 10.4.2. China
- 10.4.3. India
- 10.4.4. Australia & New Zealand
- 10.4.5. Rest of Asia Pacific
10.5. Asia Pacific Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
10.6. Asia Pacific Critical Limb Ischemia Treatment Market Forecast, by Treatment
- 10.6.1. Devices
- 10.6.2. Medication

11. Latin America Critical Limb Ischemia Treatment Market Analysis

11.1. Key Findings
11.2. Latin America Critical Limb Ischemia Treatment Market Overview
11.3. Latin America Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.4. Latin America Critical Limb Ischemia Treatment Market Forecast, by Country/Sub-region
- 11.4.1. Brazil
- 11.4.2. Mexico
- 11.4.3. Rest of Latin America
11.5. Latin America Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
11.6. Latin America Critical Limb Ischemia Treatment Market Forecast, by Treatment
- 11.6.1. Devices
- 11.6.2. Medication

12. Middle East & Africa Critical Limb Ischemia Treatment Market Analysis

12.1. Key Findings
12.2. Middle East & Africa Critical Limb Ischemia Treatment Market Overview
12.3. Middle East & Africa Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.4. Middle East & Africa Critical Limb Ischemia Treatment Market Forecast, by Country/Sub-region
- 12.4.1. GCC Countries
- 12.4.2. South Africa
- 12.4.3. Rest of Middle East & Africa
12.5. Middle East & Africa Critical Limb Ischemia Treatment Market Value Share and Attractiveness Analysis, by Treatment
12.6. Middle East & Africa Critical Limb Ischemia Treatment Market Forecast, by Treatment
- 12.6.1. Devices
- 12.6.2. Medication

13. Competition Landscape

13.1. Competition Matrix
13.2. Company Profiles
- 13.2.1. Medtronic plc
  - 13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 13.2.1.2. Product Portfolio
  - 13.2.1.3. SWOT Analysis
  - 13.2.1.4. Strategic Overview
- 13.2.2. Boston Scientific Corporation
  - 13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 13.2.2.2. Product Portfolio
  - 13.2.2.3. SWOT Analysis
  - 13.2.2.4. Strategic Overview
- 13.2.3. Cesca Therapeutics, Inc.
  - 13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 13.2.3.2. Product Portfolio
  - 13.2.3.3. SWOT Analysis
  - 13.2.3.4. Strategic Overview
- 13.2.4. Abbott Laboratories
  - 13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 13.2.4.2. Product Portfolio
  - 13.2.4.3. SWOT Analysis
  - 13.2.4.4. Strategic Overview
- 13.2.5. Pluristem Therapeutics, Inc.
  - 13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 13.2.5.2. Product Portfolio
  - 13.2.5.3. SWOT Analysis
  - 13.2.5.4. Strategic Overview
- 13.2.6. Rexgenero Ltd.
  - 13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 13.2.6.2. Product Portfolio
  - 13.2.6.3. SWOT Analysis
  - 13.2.6.4. Strategic Overview
- 13.2.7. LimFlow SA
  - 13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 13.2.7.2. Product Portfolio
  - 13.2.7.3. SWOT Analysis
  - 13.2.7.4. Strategic Overview
- 13.2.8. Micro Medical Solutions
  - 13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 13.2.8.2. Product Portfolio
  - 13.2.8.3. SWOT Analysis
  - 13.2.8.4. Strategic Overview
- 13.2.9. Cardiovascular Systems, Inc.
  - 13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 13.2.9.2. Product Portfolio
  - 13.2.9.3. SWOT Analysis
  - 13.2.9.4. Strategic Overview

Product Code: TMRGL2770

List of Tables

Table 01: Pipeline Analysis
Table 02: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
Table 03: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
Table 04: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
Table 05: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
Table 06: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Region, 2022-2031
Table 07: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country, 2022-2031
Table 08: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
Table 09: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2022-2031
Table 10: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation System, 2022-2031
Table 11: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medication, 2022-2031
Table 12: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
Table 13: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
Table 14: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2022-2031
Table 15: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation System, 2022-2031
Table 16: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medication, 2022-2031
Table 17: Asia Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
Table 18: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
Table 19: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2022-2031
Table 20: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation System, 2022-2031
Table 21: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medication, 2022-2031
Table 22: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
Table 23: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
Table 24: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2022-2031
Table 25: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation System, 2022-2031
Table 26: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medication, 2022-2031
Table 27: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
Table 28: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment, 2022-2031
Table 29: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices, 2022-2031
Table 30: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation System,
Table 31: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medication, 2022-2031
Table 32: Medtronic plc, Business Overview
Table 33: Boston Scientific Corporation Product Offerings
Table 34: Cesca Therapeutics Inc., Products & Services Offered
Table 35: Abbott Laboratories, Business Overview
Table 36: Pluristem Therapeutics Inc., Products & Services Offered
Table 37: Rexgenero Ltd, Products & Services Offered
Table 38: LimFlow SA, Products & Services Offered
Table 39: Micro Medical Solutions, Products & Services Offered
Table 40: Cardiovascular Systems, Inc., Products & Services Offered

List of Figures

Figure 01: Global Critical Limb Ischemia Treatment Market Size (US$ Mn) and Distribution, by Region, 2021 and 2031
Figure 02: Global Critical Limb Ischemia Treatment Market Revenue Projection (US$ Mn), 2022-2031
Figure 03: Global Critical Limb Ischemia Treatment Market Value Share, by Treatment, 2021
Figure 04: Global Critical Limb Ischemia Treatment Market Value Share, by Region, 2021
Figure 05: U.S. FDA Medical Devices Approval Criteria
Figure 06: Classification of Medical Devices
Figure 07: European Approval for Medical Devices - Regulatory Pathway (Class IIb Devices only)
Figure 08: Regulatory Approval Process - U.S.
Figure 09: Regulatory Approval Process - Europe
Figure 10: Regulatory Approval Process - Japan
Figure 11: Prevalence of Critical Limb Ischemia Globally/Region
Figure 12: Global Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 13: Global Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
Figure 14: Global Critical Limb Ischemia Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Devices, 2022-2031
Figure 15: Global Critical Limb Ischemia Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Medication, 2022-2031
Figure 16: Global Critical Limb Ischemia Treatment Market Value Share, by Region, 2021 and 2031
Figure 17: Global Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Region, 2022-2031
Figure 18: North America Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2031
Figure 19: North America Critical Limb Ischemia Treatment Market Value Share Analysis, by Country, 2021 and 2031
Figure 20: North America Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Country, 2022-2031
Figure 21: North America Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 22: North America Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
Figure 23: Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2031
Figure 24: Europe Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 25: Europe Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 26: Europe Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 27: Europe Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
Figure 28: Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2031
Figure 29: Asia Pacific Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 30: Asia Pacific Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 31: Asia Pacific Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 32: Asia Pacific Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
Figure 33: Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2031
Figure 34: Latin America Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 35: Latin America Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 36: Latin America Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 37: Latin America Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
Figure 38: Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2031
Figure 39: Middle East & Africa Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 40: Middle East & Africa Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 41: Middle East & Africa Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 42: Middle East & Africa Critical Limb Ischemia Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
Figure 43: Medtronic plc, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2021
Figure 44: Medtronic plc, Breakdown of Net Sales (%), by Geography, 2021
Figure 45: Medtronic plc, Breakdown of Net Sales (%), by Business Segment, 2021
Figure 46: Medtronic plc, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2021
Figure 47: Boston Scientific Corporation, Revenue (US$ Bn) and Y-o-Y Growth (%), 2018-2021
Figure 48: Boston Scientific Corporation, Breakdown of Net Sales, by Region, 2021
Figure 49: Boston Scientific Corporation, Breakdown of Net Sales, by Business Segment, 2021
Figure 50: Cesca Therapeutics Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2018-2021
Figure 51: Cesca Therapeutics Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2021
Figure 52: Cesca Therapeutics Inc. Breakdown of Net Sales, by Region, 2021
Figure 53: Cesca Therapeutics Inc. Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2021
Figure 54: Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2021
Figure 55: Abbott Laboratories, R&D Intensity and Sales & Marketing Intensity (US$ Mn), 2018-2021
Figure 56: Abbott Laboratories, Breakdown of Net Sales, by Countries, 2021
Figure 57: Abbott Laboratories, Breakdown of Net Sales, by Business Segment, 2021
Figure 58: Cardiovascular Systems, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2021
Figure 59: Cardiovascular Systems, Inc. R&D Intensity and Sales & Marketing Intensity (US$ Mn), 2018-2021

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ

Critical Limb Ischemia Treatment Market (Treatment: Medications, and Devices: Embolic Protection Devices and Peripheral Dilatation System) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Description

Table of Contents

List of Tables

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview

5. Market Outlook

6. Global Critical Limb Ischemia Treatment Market Analysis, by Treatment

7. Global Critical Limb Ischemia Treatment Market Analysis, by Region

8. North America Critical Limb Ischemia Treatment Market Analysis

9. Europe Critical Limb Ischemia Treatment Market Analysis

10. Asia Pacific Critical Limb Ischemia Treatment Market Analysis

11. Latin America Critical Limb Ischemia Treatment Market Analysis

12. Middle East & Africa Critical Limb Ischemia Treatment Market Analysis

13. Competition Landscape

List of Tables

List of Figures